Title : Imeglimin amplifies glucose-stimulated insulin release from diabetic islets via a distinct mechanism of action.

Pub. Date : 2021

PMID : 33606677






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Further, additional results suggest that NAD+ conversion to a second messenger, cyclic ADP ribose (cADPR), via ADP ribosyl cyclase/cADPR hydrolase (CD38) is required for imeglimin"s effects in islets, thus representing a potential link between increased NAD+ and enhanced glucose-induced Ca2+ mobilization which-in turn-is known to drive insulin granule exocytosis. NAD insulin Homo sapiens